ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,766.64
      0.94%
      US Tech 100
      19,655.60
      1.11%
      Dow Jones
      42,098.63
      0.73%
      Brent Oil
      76.025
      1.21%
      Bitcoin
      70,022.96
      3.25%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE

      6. KV Pharmaceutical Co. CL A (KV.A) Quote

      KV Pharmaceutical Co. CL A

      KV Pharmaceutical Co. CL A (KV.A)

      NYSE
      0.32
      0.00
      ( 0.00% )
      Updated: 19:00:00
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.32
      Bid
      -
      Ask
      -
      Volume
      0.00
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Previous Close
      0.32
      Open
      -
      Last Trade
      Last Trade Time
      -
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      KV.A Latest News

      More News

      KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million Recapitalization

      KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million Recapitalization Company Positioned For Further Growth With Focus On Products Serving...

      September 16 2013
      PR Newswire (US)

      Ther-Rx Corporation and Perrigo Company Announce the Availability of Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%...

      Ther-Rx Corporation and Perrigo Company Announce the Availability of Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%) for Prescribing /* Style Definitions...

      January 24 2013
      PR Newswire (US)

      K-V Pharmaceutical Receives Court Approval of Hologic Settlement

      K-V Pharmaceutical Receives Court Approval of Hologic Settlement /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prne...

      December 28 2012
      PR Newswire (US)

      K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of P...

      K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of Plan of Reorganization /* Style Definitions...

      December 12 2012
      PR Newswire (US)

      K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy Court

      K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy Court Follows Agreement Between the Company and Its Senior Note Holders Regarding Cash Collateral PR Newswire ST. LOUIS...

      August 10 2012
      PR Newswire (US)

      K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy Court

      K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy Court PR Newswire ST. LOUIS, Aug. 8, 2012 ST. LOUIS, Aug. 8, 2012 /PRNewswire/ -- K-V Pharmaceutical Company ("K-V" or "the...

      August 08 2012
      PR Newswire (US)

      K-V Pharmaceutical Class A and Class B Common Stock Begin Trading on the OTC Markets

      K-V Pharmaceutical Class A and Class B Common Stock Begin Trading on the OTC Markets PR Newswire ST. LOUIS, Aug. 7, 2012 ST. LOUIS, Aug. 7, 2012 /PRNewswire/ -- K-V Pharmaceutical Company ("K-V...

      August 07 2012
      PR Newswire (US)

      K-V Pharmaceutical Announces Planned Transition of Trading of Class A and Class B Common Shares to the OTC Markets

      K-V Pharmaceutical Announces Planned Transition of Trading of Class A and Class B Common Shares to the OTC Markets PR Newswire ST. LOUIS, Aug. 6, 2012 ST. LOUIS, Aug. 6, 2012 /PRNewswire/ -- K-V...

      August 06 2012
      PR Newswire (US)

      K-V Pharmaceutical Company Files Voluntary Petitions for Reorganization to Restructure Financial Obligations

      K-V Pharmaceutical Company Files Voluntary Petitions for Reorganization to Restructure Financial Obligations Company continues to operate its businesses and serve the needs of healthcare...

      August 04 2012
      PR Newswire (US)

      K-V Pharmaceutical Company Announces Additional Notification from NYSE Regarding Listing Criteria

      K-V Pharmaceutical Company Announces Additional Notification from NYSE Regarding Listing Criteria PR Newswire ST. LOUIS, July 20, 2012 ST. LOUIS, July 20, 2012 /PRNewswire/ -- K-V...

      July 20 2012
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DE
      40000000DE
      120000000DE
      260000000DE
      520000000DE
      1560000000DE
      2600000000DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ARISAris Water Solutions Inc
      $ 20.96
      (26.57%)
      		546.39k
      PLTRPalantir Technologies Inc
      $ 51.055
      (23.29%)
      		123.86M
      LICYLi Cycle Holdings Corp
      $ 3.33
      (21.98%)
      		1.24M
      FTKFlotek Industries Inc
      $ 5.7325
      (14.65%)
      		122.79k
      CLWClearWater Paper Corporation
      $ 28.745
      (13.98%)
      		477.02k
      JELDJELD WEN Holding Inc
      $ 10.09
      (-28.59%)
      		2.95M
      MAXMediaAlpha Inc
      $ 11.52
      (-28.36%)
      		1.99M
      CECelanese Corporation
      $ 93.15
      (-24.57%)
      		4.53M
      ATIPATI Physical Therapy Inc
      $ 4.095
      (-20.49%)
      		68.63k
      HYHyster Yale Inc
      $ 51.30
      (-18.16%)
      		128.66k
      PLTRPalantir Technologies Inc
      $ 51.055
      (23.29%)
      		117.48M
      ITUBItau Unibanco Holding SA
      $ 6.225
      (2.38%)
      		20.9M
      HIMSHims and Hers Health Inc
      $ 21.84
      (5.20%)
      		20.4M
      NIONIO Inc
      $ 5.30
      (3.11%)
      		16.54M
      FFord Motor Company
      $ 10.565
      (1.98%)
      		16.3M

      Discussion

      View Full Feed
      ChannelTrader ChannelTrader 3 minutes ago
      I think Trump is going to win.
      100lbStriper 100lbStriper 3 minutes ago
      cool.........but my patience is already toast!!! lol!!!
      NLST
      Trooperstocks Trooperstocks 4 minutes ago
      $ILLR $3.25 +15.55% #talkcapabilities
      https://pbs.twimg.com/media/Gboge9LbgAA6Ndx?format=png&name=900x900
      ILLR
      getmoreshares getmoreshares 4 minutes ago
      hope he rescinds the SS change--- Many name and SS changes have been denied on various positions. One holding filed for a name change over a year ago- still has not happened.
      CGAC
      Trooperstocks Trooperstocks 4 minutes ago
      $ILLR $3.25 +15.55% #talkcapabilities
      https://pbs.twimg.com/media/Gboge9LbgAA6Ndx?format=png&name=900x900
      ILLR
      twitchy twitchy 4 minutes ago
      Hopefully stronger hands on the next push will surge YUKA to new highs.
      YUKA
      SorcererDiviner18 SorcererDiviner18 4 minutes ago
      INSTITIONAL INVESTOR.

      WANTS SOME EQUITY.

      LETS GO.

      GOODBYE TOXIC LENDING.
      BEGI
      powerbattles powerbattles 5 minutes ago
      WOW! .0025. I just took one more screenshot. This is beyond criminal. SS undated. OTCN can't scare anybody now.
      AFFU
      Hoghead7 Hoghead7 5 minutes ago
      47M shares traded yesterday by 10.40am. 21M today at 11.40am. Massive difference. Should hold $.36 although would have been nice to hold $.37
      FCEL
      STOCKMONSTER STOCKMONSTER 5 minutes ago
      1000 BUCKS PER SHARE WAS SO MUCH BETTER THAN RIGHT NOW!!!!!!!!!!!!!!!!!!!!!!!!!!! NVDA LOST ALL IT'S MOJO CHASING THE A.I. DREAM!!!!!!!!!! BLAHAHHAHAAH!!!!!!!!!!!!
      NVDA
      kund kund 5 minutes ago
      comment from Lane, only guy who was bullish on AVXL in SA: Aricept (donepezil) and blarcamesine are both likely sigma-1 receptor agonists.
      pubmed.ncbi.nlm.nih.gov/...
      The affinity of Aricept for sigma-1 receptors appears to be greater than that of blarcamesine, so it is possible that
      AVXL
      IronChefQuezon IronChefQuezon 6 minutes ago
      I never blame people for taking profits. I've done it elsewhere and missed out on bigger gains. It happens. Fundamentals are too good here for me though, and I think a lot of people agree. Volume here is still very low for an OTC stock so I think there are a lot of others, like us, who are holding t
      APRU
      I-Glow I-Glow 6 minutes ago
      It's the bigger fool theory of investing - pump it - rally is imminent - so they can dump on the bigger fool.

      IG
      GVSI
      236T568 236T568 6 minutes ago
      oops, 8/10 not 9/10

      sorry
      Think1st Think1st 6 minutes ago
      Lwlg up today 3.24
      Epd up today
      LWLG
      ge11 ge11 6 minutes ago
      Comment from a different board.

      just heard that the offering was a huge success and participants could only get a portion of their interest. That means they are not interested to raise any more than needed in foreseeable future. .
      NB
      EisMCA2 EisMCA2 6 minutes ago
      200 eggs per mated couple is saying that less than 2 thirds of the eggs are going to hatch. Very low. Also, it isn't a mated couple. 1 male can fertilize 12-15 females. But, even with your lower number of 55,000, if half are female, and they can each lay 300-350 eggs each, you are looking at 8.25 mi
      KBLB
      Sltan Sltan 6 minutes ago
      RNVA foxo RNVA foxo RNVA
      RNVA
      SkeBallLarry SkeBallLarry 6 minutes ago
      " Good morning, ForrestMan " .. !!
      Slojab Slojab 7 minutes ago
      He wouldn't waste his time on tweeting worthless info.

      But when worthless info is all you got .........
      BMCS
      $GROO $GROO 7 minutes ago
      Hey Mod's how about a logo change, hmmmmm?????? 55 days to go
      SANP
      georgeofthebungle georgeofthebungle 7 minutes ago
      https://www.otcmarkets.com/stock/RDAR/news/Raadr-Inc-Announces-Agreement-with-Shareholders-for-the-Cancellation-of-1
      RDAR

      Your Recent History

      NYSE
      KV.A
      K V Pharma
      BIT
      UC5F06
      Unicredit Bank
      Delayed Upgrade Clock